Logo image of PAX

PATRIA INVESTMENTS LTD-A (PAX) Stock Fundamental Analysis

USA - NASDAQ:PAX - KYG694511059 - Common Stock

15.13 USD
+0.18 (+1.2%)
Last: 9/22/2025, 8:55:52 PM
15.13 USD
0 (0%)
After Hours: 9/22/2025, 8:55:52 PM
Fundamental Rating

5

Overall PAX gets a fundamental rating of 5 out of 10. We evaluated PAX against 236 industry peers in the Capital Markets industry. Both the profitability and the financial health of PAX get a neutral evaluation. Nothing too spectacular is happening here. PAX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year PAX was profitable.
PAX had a positive operating cash flow in the past year.
In the past 5 years PAX has always been profitable.
In the past 5 years PAX always reported a positive cash flow from operatings.
PAX Yearly Net Income VS EBIT VS OCF VS FCFPAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

The Return On Assets of PAX (5.40%) is better than 74.15% of its industry peers.
PAX's Return On Equity of 13.21% is fine compared to the rest of the industry. PAX outperforms 71.19% of its industry peers.
With an excellent Return On Invested Capital value of 12.65%, PAX belongs to the best of the industry, outperforming 87.71% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PAX is significantly above the industry average of 7.59%.
Industry RankSector Rank
ROA 5.4%
ROE 13.21%
ROIC 12.65%
ROA(3y)9.06%
ROA(5y)20.26%
ROE(3y)17.86%
ROE(5y)36.77%
ROIC(3y)15.82%
ROIC(5y)32.16%
PAX Yearly ROA, ROE, ROICPAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

PAX has a Profit Margin (18.47%) which is comparable to the rest of the industry.
PAX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 33.99%, PAX is in the better half of the industry, outperforming 60.59% of the companies in the same industry.
In the last couple of years the Operating Margin of PAX has declined.
PAX's Gross Margin of 51.51% is fine compared to the rest of the industry. PAX outperforms 60.59% of its industry peers.
In the last couple of years the Gross Margin of PAX has declined.
Industry RankSector Rank
OM 33.99%
PM (TTM) 18.47%
GM 51.51%
OM growth 3Y-15.59%
OM growth 5Y-8.18%
PM growth 3Y-28.26%
PM growth 5Y-16.57%
GM growth 3Y-5.8%
GM growth 5Y-4.11%
PAX Yearly Profit, Operating, Gross MarginsPAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, PAX has more shares outstanding
The number of shares outstanding for PAX has been increased compared to 5 years ago.
The debt/assets ratio for PAX is higher compared to a year ago.
PAX Yearly Shares OutstandingPAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
PAX Yearly Total Debt VS Total AssetsPAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

PAX has an Altman-Z score of 2.44. This is not the best score and indicates that PAX is in the grey zone with still only limited risk for bankruptcy at the moment.
PAX has a Altman-Z score of 2.44. This is in the better half of the industry: PAX outperforms 72.88% of its industry peers.
The Debt to FCF ratio of PAX is 1.10, which is an excellent value as it means it would take PAX, only 1.10 years of fcf income to pay off all of its debts.
PAX's Debt to FCF ratio of 1.10 is amongst the best of the industry. PAX outperforms 90.25% of its industry peers.
PAX has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, PAX is in the better half of the industry, outperforming 73.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.1
Altman-Z 2.44
ROIC/WACCN/A
WACCN/A
PAX Yearly LT Debt VS Equity VS FCFPAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

PAX has a Current Ratio of 0.97. This is a bad value and indicates that PAX is not financially healthy enough and could expect problems in meeting its short term obligations.
PAX has a Current ratio (0.97) which is in line with its industry peers.
A Quick Ratio of 0.97 indicates that PAX may have some problems paying its short term obligations.
PAX's Quick ratio of 0.97 is in line compared to the rest of the industry. PAX outperforms 45.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
PAX Yearly Current Assets VS Current LiabilitesPAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.27% over the past year.
Measured over the past 5 years, PAX shows a small growth in Earnings Per Share. The EPS has been growing by 1.20% on average per year.
PAX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.64%.
Measured over the past years, PAX shows a very strong growth in Revenue. The Revenue has been growing by 24.89% on average per year.
EPS 1Y (TTM)13.27%
EPS 3Y6.45%
EPS 5Y1.2%
EPS Q2Q%9.09%
Revenue 1Y (TTM)13.64%
Revenue growth 3Y16.7%
Revenue growth 5Y24.89%
Sales Q2Q%10%

3.2 Future

The Earnings Per Share is expected to decrease by -4.48% on average over the next years.
The Revenue is expected to grow by 18.80% on average over the next years. This is quite good.
EPS Next Y-3.07%
EPS Next 2Y-6.79%
EPS Next 3Y-4.48%
EPS Next 5YN/A
Revenue Next Year17.26%
Revenue Next 2Y19.25%
Revenue Next 3Y18.8%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PAX Yearly Revenue VS EstimatesPAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
PAX Yearly EPS VS EstimatesPAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.82 indicates a reasonable valuation of PAX.
PAX's Price/Earnings ratio is a bit cheaper when compared to the industry. PAX is cheaper than 66.10% of the companies in the same industry.
PAX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
A Price/Forward Earnings ratio of 14.04 indicates a correct valuation of PAX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PAX is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of PAX to the average of the S&P500 Index (22.87), we can say PAX is valued slightly cheaper.
Industry RankSector Rank
PE 11.82
Fwd PE 14.04
PAX Price Earnings VS Forward Price EarningsPAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PAX is valued cheaply inside the industry as 83.05% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PAX indicates a somewhat cheap valuation: PAX is cheaper than 68.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.35
EV/EBITDA 14.04
PAX Per share dataPAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PAX has a very decent profitability rating, which may justify a higher PE ratio.
PAX's earnings are expected to decrease with -4.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)9.86
EPS Next 2Y-6.79%
EPS Next 3Y-4.48%

3

5. Dividend

5.1 Amount

PAX has a Yearly Dividend Yield of 3.93%.
Compared to an average industry Dividend Yield of 8.21, PAX has a dividend in line with its industry peers.
PAX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.93%

5.2 History

PAX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PAX Yearly Dividends per sharePAX Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

133.26% of the earnings are spent on dividend by PAX. This is not a sustainable payout ratio.
DP133.26%
EPS Next 2Y-6.79%
EPS Next 3Y-4.48%
PAX Yearly Income VS Free CF VS DividendPAX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 50M 100M
PAX Dividend Payout.PAX Dividend Payout, showing the Payout Ratio.PAX Dividend Payout.PayoutRetained Earnings

PATRIA INVESTMENTS LTD-A

NASDAQ:PAX (9/22/2025, 8:55:52 PM)

After market: 15.13 0 (0%)

15.13

+0.18 (+1.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners70.84%
Inst Owner Change7.49%
Ins Owners0.34%
Ins Owner ChangeN/A
Market Cap2.41B
Analysts74
Price Target16.32 (7.87%)
Short Float %4.09%
Short Ratio5.37
Dividend
Industry RankSector Rank
Dividend Yield 3.93%
Yearly Dividend0.88
Dividend Growth(5Y)N/A
DP133.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-15 2025-08-15 (0.15)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.37%
Min EPS beat(2)-8.91%
Max EPS beat(2)65.65%
EPS beat(4)1
Avg EPS beat(4)11.96%
Min EPS beat(4)-8.91%
Max EPS beat(4)65.65%
EPS beat(8)3
Avg EPS beat(8)2.16%
EPS beat(12)5
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)24.05%
Revenue beat(2)1
Avg Revenue beat(2)21.24%
Min Revenue beat(2)-26.12%
Max Revenue beat(2)68.61%
Revenue beat(4)3
Avg Revenue beat(4)12.95%
Min Revenue beat(4)-26.12%
Max Revenue beat(4)68.61%
Revenue beat(8)6
Avg Revenue beat(8)12.75%
Revenue beat(12)8
Avg Revenue beat(12)10.77%
Revenue beat(16)11
Avg Revenue beat(16)26.22%
PT rev (1m)3.23%
PT rev (3m)7.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.25%
Revenue NY rev (1m)0.86%
Revenue NY rev (3m)-7.73%
Valuation
Industry RankSector Rank
PE 11.82
Fwd PE 14.04
P/S 6.18
P/FCF 12.35
P/OCF 11.82
P/B 4.42
P/tB N/A
EV/EBITDA 14.04
EPS(TTM)1.28
EY8.46%
EPS(NY)1.08
Fwd EY7.12%
FCF(TTM)1.22
FCFY8.1%
OCF(TTM)1.28
OCFY8.46%
SpS2.45
BVpS3.42
TBVpS-1.45
PEG (NY)N/A
PEG (5Y)9.86
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 13.21%
ROCE 14.37%
ROIC 12.65%
ROICexc 14.28%
ROICexgc 287.19%
OM 33.99%
PM (TTM) 18.47%
GM 51.51%
FCFM 50.05%
ROA(3y)9.06%
ROA(5y)20.26%
ROE(3y)17.86%
ROE(5y)36.77%
ROIC(3y)15.82%
ROIC(5y)32.16%
ROICexc(3y)24.59%
ROICexc(5y)50.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.97%
ROCE(5y)36.54%
ROICexcg growth 3Y69.86%
ROICexcg growth 5Y42.83%
ROICexc growth 3Y-16.38%
ROICexc growth 5Y-27.63%
OM growth 3Y-15.59%
OM growth 5Y-8.18%
PM growth 3Y-28.26%
PM growth 5Y-16.57%
GM growth 3Y-5.8%
GM growth 5Y-4.11%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.1
Debt/EBITDA 0.98
Cap/Depr 22%
Cap/Sales 2.24%
Interest Coverage 93.68
Cash Conversion 118.33%
Profit Quality 270.95%
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 2.44
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)26.69%
Cap/Depr(5y)21.94%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.65%
Profit Quality(3y)132.69%
Profit Quality(5y)113.61%
High Growth Momentum
Growth
EPS 1Y (TTM)13.27%
EPS 3Y6.45%
EPS 5Y1.2%
EPS Q2Q%9.09%
EPS Next Y-3.07%
EPS Next 2Y-6.79%
EPS Next 3Y-4.48%
EPS Next 5YN/A
Revenue 1Y (TTM)13.64%
Revenue growth 3Y16.7%
Revenue growth 5Y24.89%
Sales Q2Q%10%
Revenue Next Year17.26%
Revenue Next 2Y19.25%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
EBIT growth 1Y1.45%
EBIT growth 3Y-1.48%
EBIT growth 5Y14.68%
EBIT Next Year45.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.79%
FCF growth 3Y9.2%
FCF growth 5Y25.48%
OCF growth 1Y142.79%
OCF growth 3Y10.71%
OCF growth 5Y26.83%